Middlekauff W Bradford is CBO, GC and Secretary of Tourmaline Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Tourmaline Bio, Inc.
23 Oct 23
3
Tourmaline Bio, Inc.
23 Oct 23
4
Immunovant, Inc.
18 May 20
4
Immunovant, Inc.
20 Dec 19
3
Immunovant, Inc.
20 Dec 19
4
Edge Therapeutics, Inc.
18 Mar 19
4/A
Edge Therapeutics, Inc.
31 Dec 18
4
Edge Therapeutics, Inc.
15 Aug 18
4
Edge Therapeutics, Inc.
20 Jun 18
4
Edge Therapeutics, Inc.
5 Mar 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Oct 23 | TRML Tourmaline Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 9.46 | 46,774 | 442.48 k | 46,774 |
19 Oct 23 | TRML Tourmaline Bio | Common Stock | Grant | Acquire A | No | No | 0 | 69,201 | 0.00 | 69,201 |
19 Oct 23 | TRML Tourmaline Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 7.9 | 124,991 | 987.43 k | 124,991 |